Variant report
Variant | nsv1059498 |
---|---|
Chromosome Location | chr19:56331762-56369132 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:78)
- CpG islands (count:1100)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr19:56347744-56348093 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr19:56342078-56342348 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr19:56342129-56342342 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr19:56342021-56342353 | Hela-S3 | cervix: | n/a | n/a |
5 | CEBPB | chr19:56341872-56342423 | HCT-116 | colon: | n/a | n/a |
6 | CEBPB | chr19:56342114-56342249 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr19:56341826-56342415 | HCT-116 | colon: | n/a | n/a |
8 | CEBPB | chr19:56344099-56344348 | A549 | lung: | n/a | n/a |
9 | CREB1 | chr19:56368555-56368853 | GM12878 | blood: | n/a | n/a |
10 | CTCF | chr19:56366525-56366565 | Lung_OC | lung: | n/a | n/a |
11 | CTCF | chr19:56367060-56367210 | GM12878 | blood: | n/a | n/a |
12 | CTCF | chr19:56359283-56359341 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr19:56359262-56359360 | MCF-7 | breast: | n/a | n/a |
14 | CTCF | chr19:56361586-56361622 | GM10266 | blood: | n/a | n/a |
15 | E2F6 | chr19:56347750-56348013 | K562 | blood: | n/a | chr19:56347894-56347903 chr19:56347850-56347859 |
16 | EBF1 | chr19:56332910-56333204 | GM12878 | blood: | n/a | n/a |
17 | ELF1 | chr19:56347699-56348090 | K562 | blood: | n/a | n/a |
18 | EP300 | chr19:56362226-56362450 | GM12878 | blood: | n/a | n/a |
19 | EP300 | chr19:56361456-56362056 | GM12878 | blood: | n/a | n/a |
20 | EP300 | chr19:56341997-56342300 | K562 | blood: | n/a | n/a |
21 | FOXA1 | chr19:56334071-56334328 | HepG2 | liver: | n/a | n/a |
22 | FOXA2 | chr19:56333882-56334592 | A549 | lung: | n/a | n/a |
23 | FOXM1 | chr19:56361910-56362568 | GM12878 | blood: | n/a | n/a |
24 | GABPA | chr19:56361817-56361985 | GM12878 | blood: | n/a | n/a |
25 | GABPA | chr19:56361597-56361816 | GM12878 | blood: | n/a | n/a |
26 | IRF4 | chr19:56368521-56368818 | GM12878 | blood: | n/a | n/a |
27 | JUN | chr19:56347825-56347971 | K562 | blood: | n/a | chr19:56347852-56347861 chr19:56347929-56347937 chr19:56347928-56347938 chr19:56347927-56347939 chr19:56347926-56347934 |
28 | JUN | chr19:56355961-56356072 | HepG2 | liver: | n/a | chr19:56356003-56356016 |
29 | JUND | chr19:56355865-56356146 | HepG2 | liver: | n/a | n/a |
30 | JUND | chr19:56347784-56348072 | K562 | blood: | n/a | chr19:56347852-56347861 chr19:56347929-56347937 chr19:56347928-56347938 chr19:56347927-56347939 chr19:56347926-56347934 |
31 | MAFF | chr19:56347779-56348078 | K562 | blood: | n/a | n/a |
32 | MAFF | chr19:56342042-56342286 | HepG2 | liver: | n/a | chr19:56342165-56342183 |
33 | MAFK | chr19:56350683-56350912 | HepG2 | liver: | n/a | chr19:56350794-56350809 |
34 | MAFK | chr19:56347911-56347951 | HepG2 | liver: | n/a | chr19:56347930-56347939 |
35 | MAFK | chr19:56350751-56350832 | HepG2 | liver: | n/a | chr19:56350794-56350809 |
36 | MAFK | chr19:56342026-56342311 | HepG2 | liver: | n/a | chr19:56342168-56342179 chr19:56342168-56342179 |
37 | MAFK | chr19:56342043-56342260 | HepG2 | liver: | n/a | chr19:56342168-56342179 chr19:56342168-56342179 |
38 | MAFK | chr19:56347776-56348050 | K562 | blood: | n/a | chr19:56347930-56347939 |
39 | MAX | chr19:56347804-56348040 | K562 | blood: | n/a | n/a |
40 | MAX | chr19:56347766-56348071 | K562 | blood: | n/a | n/a |
41 | MAX | chr19:56347783-56348100 | K562 | blood: | n/a | n/a |
42 | MEF2A | chr19:56368609-56368882 | GM12878 | blood: | n/a | n/a |
43 | MEF2C | chr19:56368514-56368871 | GM12878 | blood: | n/a | n/a |
44 | MYC | chr19:56342823-56342885 | MCF-7 | breast: | n/a | n/a |
45 | MYC | chr19:56342203-56342208 | K562 | blood: | n/a | n/a |
46 | MYC | chr19:56349203-56349219 | GM12878 | blood: | n/a | n/a |
47 | MYC | chr19:56359326-56359360 | MCF-7 | breast: | n/a | n/a |
48 | MYC | chr19:56347797-56347868 | K562 | blood: | n/a | n/a |
49 | NFYA | chr19:56347753-56348022 | K562 | blood: | n/a | chr19:56347848-56347861 chr19:56347848-56347862 chr19:56347821-56347833 chr19:56347847-56347859 |
50 | NFYB | chr19:56347717-56348060 | K562 | blood: | n/a | chr19:56347848-56347861 chr19:56347848-56347862 chr19:56347821-56347833 chr19:56347847-56347859 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56367316-56367366 | HRE | kidney: | n/a |
2 | chr19:56348889-56348939 | HEEpiC | esophagus: | n/a |
3 | chr19:56367316-56367366 | HRE | kidney: | n/a |
4 | chr19:56348889-56348939 | HEEpiC | esophagus: | n/a |
5 | chr19:56364183-56364233 | HepG2 | liver: | n/a |
6 | chr19:56363105-56363155 | HRCEpiC | kidney: | n/a |
7 | chr19:56348216-56348266 | AG04449 | skin: | fetal |
8 | chr19:56348742-56348792 | PFSK-1 | brain: | n/a |
9 | chr19:56364183-56364233 | HEK293 | kidney: | embryo |
10 | chr19:56347722-56347772 | HAEpiC | amniotic membrane: | n/a |
11 | chr19:56346628-56346678 | ProgFib | skin: | n/a |
12 | chr19:56347870-56347920 | BJ | skin: | n/a |
13 | chr19:56367316-56367366 | HCPEpiC | choroid plexus: | n/a |
14 | chr19:56347771-56347821 | AG10803 | skin: | n/a |
15 | chr19:56347927-56347977 | HRPEpiC | eye: | n/a |
16 | chr19:56348889-56348939 | K562 | blood: | n/a |
17 | chr19:56348889-56348939 | PANC-1 | pancreas: | n/a |
18 | chr19:56347870-56347920 | AG09309 | skin: | n/a |
19 | chr19:56348889-56348939 | HL-60 | blood: | n/a |
20 | chr19:56367830-56367880 | HCPEpiC | choroid plexus: | n/a |
21 | chr19:56346743-56346793 | CMK | blood: | n/a |
22 | chr19:56348742-56348792 | BE2_C | brain: | n/a |
23 | chr19:56347870-56347920 | Hepatocyte | liver: | n/a |
24 | chr19:56347771-56347821 | HRCEpiC | kidney: | n/a |
25 | chr19:56367316-56367366 | NB4 | blood: | n/a |
26 | chr19:56349119-56349169 | HCF | heart: | n/a |
27 | chr19:56342665-56342715 | LNCaP | prostate: | n/a |
28 | chr19:56361716-56361766 | NT2-D1 | testis: | n/a |
29 | chr19:56347927-56347977 | GM12878 | blood: | n/a |
30 | chr19:56364183-56364233 | HIPEpiC | eye: | n/a |
31 | chr19:56349119-56349169 | HIPEpiC | eye: | n/a |
32 | chr19:56346628-56346678 | NB4 | blood: | n/a |
33 | chr19:56347722-56347772 | GM06990 | blood: | n/a |
34 | chr19:56367316-56367366 | HPAEpiC | pulmonary alveolar: | n/a |
35 | chr19:56348216-56348266 | AoSMC | blood vessel: | n/a |
36 | chr19:56363105-56363155 | LNCaP | prostate: | n/a |
37 | chr19:56347847-56347897 | ProgFib | skin: | n/a |
38 | chr19:56347870-56347920 | Hela-S3 | cervix: | n/a |
39 | chr19:56366191-56366241 | Caco-2 | colon: | n/a |
40 | chr19:56347771-56347821 | ProgFib | skin: | n/a |
41 | chr19:56347927-56347977 | K562 | blood: | n/a |
42 | chr19:56364183-56364233 | AG10803 | skin: | n/a |
43 | chr19:56347847-56347897 | HRPEpiC | eye: | n/a |
44 | chr19:56349119-56349169 | GM12878 | blood: | n/a |
45 | chr19:56349119-56349169 | T-47D | breast: | n/a |
46 | chr19:56347722-56347772 | SKMC | muscle: | n/a |
47 | chr19:56364183-56364233 | AG04450 | lung: | fetal |
48 | chr19:56349119-56349169 | GM12892 | blood: | n/a |
49 | chr19:56366191-56366241 | BJ | skin: | n/a |
50 | chr19:56347927-56347977 | ovcar-3 | ovarian: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NLRP11 | TF binding region |
NLRP4 | TF binding region |
NLRP11 | CpG island |
NLRP4 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370314959 | chr19:56331776-56331777 | ZNF genes & repeats Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191663949 | chr19:56331797-56331798 | ZNF genes & repeats Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375386946 | chr19:56331820-56331821 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541544130 | chr19:56331832-56331833 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561785486 | chr19:56331846-56331847 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373043677 | chr19:56331869-56331870 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527390032 | chr19:56331881-56331882 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548019125 | chr19:56331888-56331889 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2112827 | chr19:56331905-56331906 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs7259889 | chr19:56331911-56331912 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184974022 | chr19:56331918-56331919 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550463747 | chr19:56331933-56331934 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2112826 | chr19:56331935-56331936 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs535802802 | chr19:56332018-56332019 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374670244 | chr19:56332025-56332026 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549507087 | chr19:56332026-56332027 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368400110 | chr19:56332037-56332038 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs58906242 | chr19:56332049-56332050 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10560594 | chr19:56332053-56332054 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546827459 | chr19:56332104-56332105 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs553959419 | chr19:56332120-56332121 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs386811116 | chr19:56332137-56332138 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs2616951 | chr19:56332139-56332140 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs114609416 | chr19:56332141-56332142 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs574113904 | chr19:56332158-56332159 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs79301205 | chr19:56332176-56332177 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs117478805 | chr19:56332178-56332179 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs34132451 | chr19:56332199-56332200 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs555068067 | chr19:56332217-56332218 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs5828649 | chr19:56332223-56332224 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs536238909 | chr19:56332243-56332244 | ZNF genes & repeats Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs2616950 | chr19:56332270-56332271 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs2547268 | chr19:56332289-56332290 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs74467178 | chr19:56332331-56332332 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34774826 | chr19:56332347-56332348 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201487301 | chr19:56332352-56332353 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375136022 | chr19:56332353-56332354 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2164657 | chr19:56332374-56332375 | ZNF genes & repeats Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs371811141 | chr19:56332391-56332392 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150844740 | chr19:56332487-56332488 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs146995362 | chr19:56332556-56332557 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564266986 | chr19:56332570-56332571 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2086096 | chr19:56332571-56332572 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs74181752 | chr19:56332572-56332573 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76720441 | chr19:56332573-56332574 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79830148 | chr19:56332575-56332576 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111761029 | chr19:56332577-56332578 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112456064 | chr19:56332579-56332580 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4801632 | chr19:56332580-56332581 | ZNF genes & repeats Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141604806 | chr19:56332604-56332605 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56329600-56334200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
2 | chr19:56330200-56331800 | Flanking Active TSS | GM12878-XiMat | blood |
3 | chr19:56330200-56332000 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr19:56331200-56331800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
5 | chr19:56331800-56332600 | Enhancers | GM12878-XiMat | blood |
6 | chr19:56333400-56334000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
7 | chr19:56333800-56334200 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr19:56333800-56334200 | Active TSS | Primary T cells fromperipheralblood | blood |
9 | chr19:56342200-56342600 | Active TSS | HSMM | muscle |
10 | chr19:56347600-56348200 | Active TSS | A549 | lung |
11 | chr19:56357800-56358000 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr19:56359400-56361200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr19:56360400-56361000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr19:56360400-56361400 | ZNF genes & repeats | Monocytes-CD14+_RO01746 | blood |
15 | chr19:56363400-56364600 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
16 | chr19:56364600-56372200 | Enhancers | Primary B cells from peripheral blood | blood |
17 | chr19:56365200-56365400 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr19:56366400-56366800 | Enhancers | GM12878-XiMat | blood |
19 | chr19:56366800-56367000 | Flanking Active TSS | GM12878-XiMat | blood |
20 | chr19:56367000-56367200 | Enhancers | GM12878-XiMat | blood |
21 | chr19:56367200-56367400 | Flanking Active TSS | GM12878-XiMat | blood |
22 | chr19:56367400-56368200 | Enhancers | GM12878-XiMat | blood |
23 | chr19:56368200-56368800 | Weak transcription | GM12878-XiMat | blood |
24 | chr19:56368800-56369000 | Active TSS | GM12878-XiMat | blood |
25 | chr19:56369000-56369200 | Flanking Active TSS | GM12878-XiMat | blood |